I consent to the use of cookies on this page for analyses, personalised content and advertising.

Flivasorb® and Flivasorb Border

Superabsorbent dressings with extremely high absorption and retention capacities

Fields of application

Flivasorb is indicated for the management of acute and chronic wounds with moderate to high levels or exudate including:

  • Diabetic foot ulcers 
  • Venous leg ulcers
  • Pressure ulcers
  • Postoperative wound healing by secondary intention

Features/ Benefits

  • very high capacity to absorb and retain wound exudate
  • absorbent core with superabsorber, which can absorb up to 20 times weight
  • cost and time savings fewer dressing changes
  • protect the wound edge from maceration and promote wound healing through providing a moist wound environment
  • attractive to patients:

    • thin
    • flexible
    • cushioning

  • reduces the risk of adhering to the wound
  • with clothing protection

To note

  • Do not cut the dressing

Super absorbent fiber core absorb many times its own weight in fluids and does not release the retained exudate even under mechanical pressure. This is how the wound margins are protected from maceration and makes Flivasorb the comfortable wound dressing choice under compression bandages.

Managing heavily exuding wounds can be costly when valuable time and resources are spent on frequent dressing changes. Flivasorb super absorbent dressing, with its very high absorption capacity, helps allow for fewer dressing changes which saves time and money.

Findings

  • female
  • aged 88
  • long-existing lower leg ulcer

Concomitant diseases

  • diabetes mellitus
  • post trauma

Previous therapy

  • pointment tulle
  • absorbent dressing
  • daily dressing change

Treatment

  • wound cleansing
  • antiseptic with Octenisept
  • application of Flivasorb
  • retention with Suprasorb F

From Treatment Day 11

  •  switch to treatment with less absorbent materials

Findings

  • female
  • aged 77
  • pretibial haematoma with left frontal laceration
  • post pulmonary embolism
  • type II heparin-induced thrombocytopenia with heparin allergy

Previous therapy

  • Suprasorb CNP (CNP = Controlled Negative Pressure)

Treatment

  • wound cleansing
  • antiseptic with Octenisept
  • application of Flivasorb
  • retention with Suprasorb F
  • phlebological compression

From Treatment Day 13

  •  switch to treatment with less absorbent materials

Product composition

Non-adhesive version:

  • Absorbent pad: polyethylene, polypropylene, cellulose, sodium polyacrylate (superabsorber polymers).
  • Backing layer: blue, non-woven polypropylene fibers

Adhesive version:

  • Absorbent pad: polyethylene, polypropylene, cellulose, sodium polyacrylate (superabsorber polymers).
  • Backing layer: polyurethane membrane with skin-friendly polyacrylate adhesive (free of colophony and colophony derivates).

Versions

  • Non-adhesive
  • Adhesive border

Ordering information

Flivasorb

sterile, individually sealed
Size (cm)REFShipping Units
10 x 102581010 each per bx
10 x 202581110 each per bx
20 x 202581210 each per bx
20 x 30
25910
10 each per bx